Synthesis of novel pyrazole-thiadiazole hybrid as potential potent and selective cyclooxygenase-2 (COX-2) inhibitors

被引:43
作者
Alegaon, S. G. [1 ]
Hirpara, M. B. [1 ]
Alagawadi, K. R. [1 ]
Hullatti, K. K. [2 ]
Kashniyal, K. [1 ]
机构
[1] KLE Univ, KLES Coll Pharm, Dept Pharmaceut Chem, Belgaum 590010, Karnataka, India
[2] KLE Univ, KLES Coll Pharm, Dept Pharmacognosy, Belgaum 590010, Karnataka, India
关键词
Pyrazoles; Thiadiazole; COX-1 and COX-2; Cytotoxicity; Docking; Drug likeness; BIOLOGICAL EVALUATION; MOLECULAR DOCKING; DERIVATIVES; DISCOVERY; DESIGN; SERIES; ACID;
D O I
10.1016/j.bmcl.2014.08.062
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 1,3,4-trisubstituted pyrazole derivatives (3a-f), (4a-f), and (5a-f) have been synthesized and evaluated for their cyclooxygenase (COX-1 and COX-2) inhibitory activity. The structures of newly synthesized compounds were characterized by IR, H-1 NMR, and mass spectral analysis. All of the compounds showed good inhibition of COX-2 with IC50 of 1.33-17.5 mu M. Among these derivatives, compound (5c) was the most potent and selective COX-2 inhibitor (IC50 = 1.33 mu M), with a significant selectivity index (SI >60). Molecular docking studies were carried out in order to predict the hypothetical binding mode of these compounds to the COX-2 isoenzyme. The result of present study suggests that pyrazole-thiadiazole hybrid could be an interesting approach for the design of new selective COX-2 inhibitory agents. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5324 / 5329
页数:6
相关论文
共 32 条
[1]  
Alegaon S G, 2014, Drug Res (Stuttg), V64, P553, DOI 10.1055/s-0033-1363976
[2]   Synthesis, characterization, and biological evaluation of thiazolidine-2,4-dione derivatives [J].
Alegaon, Shankar G. ;
Alagawadi, Kallanagouda R. ;
Pawar, Sneha M. ;
Vinod, D. ;
Rajput, Udaysingh .
MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (02) :987-994
[3]   New thiazolidine-2,4-diones as antimicrobial and cytotoxic agent [J].
Alegaon, Shankar G. ;
Alagawadi, Kallanagouda R. .
MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (10) :3214-3223
[4]   Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents [J].
Alegaon, Shankar G. ;
Alagawadi, Kallanagouda R. ;
Sonkusare, Pranali V. ;
Chaudhary, Sagar M. ;
Dadwe, Dilip H. ;
Shah, Amol S. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (05) :1917-1921
[5]  
Alegaon SG, 2011, LETT DRUG DES DISCOV, V8, P612
[6]   Synthesis and biological evaluation of some 5-arylidene-2-(1,3-thiazol-2-ylimino)-1,3-thiazolidin-4-ones as dual anti-inflammatory/antimicrobial agents [J].
Apostolidis, I. ;
Liaras, K. ;
Geronikaki, A. ;
Hadjipavlou-Litina, D. ;
Gavalas, A. ;
Sokovic, M. ;
Glamoclija, J. ;
Ciric, A. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (02) :532-539
[7]   Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents [J].
Bandgar, Babasaheb P. ;
Gawande, Shrikant S. ;
Bodade, Ragini G. ;
Gawande, Nalini M. ;
Khobragade, Chandrahasya N. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (24) :8168-8173
[8]   Synthesis of novel celecoxib analogues by bioisosteric replacement of sulfonamide as potent anti-inflammatory agents and cyclooxygenase inhibitors [J].
Chandna, Nisha ;
Kumar, Satish ;
Kaushik, Pawan ;
Kaushik, Dhirender ;
Roy, Somendu K. ;
Gupta, Girish K. ;
Jachak, Sanjay M. ;
Kapoor, Jitander K. ;
Sharma, Pawan K. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (15) :4581-4590
[9]   Cyclooxygenase inhibitors - current status and future prospects [J].
Dannhardt, G ;
Kiefer, W .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (02) :109-126
[10]   Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2 [J].
El-Sayed, Magda A. -A. ;
Abdel-Aziz, Naglaa I. ;
Abdel-Aziz, Alaa A. -M. ;
El-Azab, Adel S. ;
ElTahir, Kamal E. H. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (10) :3306-3316